|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acne Vulgaris | |||||
| 2 | More general conditions related to this trial | ||||
| Acneiform Eruptions | |||||
| Facial Dermatoses | |||||
| Sebaceous Gland Diseases | |||||
| Skin Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| IDP-110 | |||||
| Clindamycin | |||||
| Benzoyl peroxide | |||||
| Vehicle | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Protein Synthesis Inhibitors | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Dow Pharmaceutical Sciences | |||||